10x Genomics (TXG) 2024年第四季度财报电话会议记录 - AOL.com
10x Genomics (TXG) Q4 2024 Earnings Transcript - AOL.com
生物技术与制药领域的最新动态
10x Genomics (TXG) Q4 2024 Earnings Transcript - AOL.com
10x Genomics (TXG) Q2 2025 Earnings Transcript - AOL.com
TXG: Citigroup Downgrades 10x Genomics to Neutral with $18 Price Target | TXG Stock News - GuruFocus
10x Genomics (TXG) Q2 2025 Earnings Transcript - The Motley Fool
Citi Downgrades 10x Genomics(TXG.US) to Hold Rating, Raises Target Price to $18 - 富途牛牛
Why 10x Genomics (TXG) Stock Is Nosediving - Finviz
10x Genomics downgraded to Neutral from Buy at Citi - TipRanks
Why 10x Genomics (TXG) Stock Is Nosediving - TradingView — Track All Markets
Why 10x Genomics (TXG) Stock Is Nosediving - Yahoo Finance
Why 10x Genomics (TXG) Stock Is Nosediving - Markets Financial Content
10x Genomics Shares Slide Amid Downgrade and Insider Selling - TipRanks
Citigroup Downgrades 10x Genomics to Neutral From Buy, Price Target is $18 - marketscreener.com
NeurIPS 2025: Biology’s Transformer Moment - Genetic Engineering and Biotechnology News
10x Genomics $TXG Shares Bought by Jump Financial LLC - MarketBeat
NeurIPS 2025: Altos Labs Wins Generalist Prize at Arc’s Virtual Cell Challenge - Genetic Engineering and Biotechnology News
Is 10x Genomics Stock Built to Withstand More Downside? - Trefis
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - TradingView
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - Markets Financial Content
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - Finviz
10x Genomics (TXG) Is Down 5.5% After Morgan Stanley Downgrade Has The Bull Case Changed? - simplywall.st